We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Benefit of Breast Conservation Therapy Confirmed

By HospiMedica staff writers
Posted on 10 Apr 2001
A community study of 626 women who had breast conservation therapy for invasive breast cancer over a 14-year period showed that the recurrence rate was 4% at five years and 8% at 10 years, confirming the findings of national studies. More...
The study was presented at the European Conference on Strategies and Outcomes, in Edinburgh (UK), by doctors from the Radiotherapy Clinics of Georgia (RCOG, Atlanta, USA).

Breast conservation therapy (BCT) allows a woman to keep her breast by removing the tumor (lumpectomy), followed by radiation therapy, which controls microscopic cancer and reduces the recurrence rate by 75%. A second study examined 110 women diagnosed with ductal carcinoma-in-situ, a pre-malignant condition that can progress to invasive cancer. These women were also treated with lumpectomy and radiation therapy over a 14-year period. The breast cancer recurrence rate was 2% at five years and 10% at 10 years.

According to the RCOG, these studies are significant because they represent the largest data set presented by a U.S. community-based treatment program and they reveal the effectiveness of BCT outside the clinical trial and academic institution setting. "The low recurrence rates in these studies document that with careful quality control, excellent results, equivalent to national series, can be achieved in the community setting,” said Dr. Hamilton Williams, a RCOG doctor.

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.